Oxford Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | $13K | Sell |
15,239
-202,329
| -93% | -$173K | ﹤0.01% | 193 |
|
2019
Q4 | $209K | Sell |
217,568
-75,375
| -26% | -$72.4K | 0.01% | 1544 |
|
2019
Q3 | $302K | Sell |
292,943
-52,936
| -15% | -$54.6K | 0.01% | 1457 |
|
2019
Q2 | $623K | Sell |
345,879
-59,704
| -15% | -$108K | 0.01% | 1178 |
|
2019
Q1 | $762K | Sell |
405,583
-91,615
| -18% | -$172K | 0.02% | 1047 |
|
2018
Q4 | $587K | Sell |
497,198
-12,192
| -2% | -$14.4K | 0.02% | 1125 |
|
2018
Q3 | $1.33M | Buy |
+509,390
| New | +$1.33M | 0.03% | 876 |
|
2017
Q1 | – | Sell |
-343,172
| Closed | -$463K | – | 1489 |
|
2016
Q4 | $463K | Buy |
343,172
+133,310
| +64% | +$180K | 0.02% | 595 |
|
2016
Q3 | $327K | Sell |
209,862
-561,644
| -73% | -$875K | 0.01% | 660 |
|
2016
Q2 | $1.03M | Sell |
771,506
-4,730
| -0.6% | -$6.29K | 0.03% | 480 |
|
2016
Q1 | $4.09M | Sell |
776,236
-186,371
| -19% | -$982K | 0.12% | 209 |
|
2015
Q4 | $7.55M | Buy |
962,607
+949,935
| +7,496% | +$7.45M | 0.18% | 115 |
|
2015
Q3 | $107K | Sell |
12,672
-697,726
| -98% | -$5.89M | ﹤0.01% | 598 |
|
2015
Q2 | $7.78M | Buy |
710,398
+419,332
| +144% | +$4.59M | 0.21% | 109 |
|
2015
Q1 | $4.07M | Sell |
291,066
-291,023
| -50% | -$4.07M | 0.1% | 226 |
|
2014
Q4 | $9.93M | Buy |
+582,089
| New | +$9.93M | 0.22% | 85 |
|
2013
Q4 | – | Sell |
-303,934
| Closed | -$5.3M | – | 810 |
|
2013
Q3 | $5.3M | Sell |
303,934
-507,397
| -63% | -$8.85M | 0.12% | 226 |
|
2013
Q2 | $13.2M | Buy |
+811,331
| New | +$13.2M | 0.36% | 47 |
|